Related Experiment Video
Updated: Jul 24, 2026
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Management of urticaria: a consensus report
T Zuberbier1, M W Greaves, L Juhlin
1Department of Dermatology and Allergy, Charité, Humboldt University, Berlin, Germany. torsten.zuberbier@charite.de
The Journal of Investigative Dermatology. Symposium Proceedings
|January 5, 2002
Summary
Effective urticaria treatment requires H1 antihistamines, potentially at higher doses. Alternative therapies may be needed for varied patient responses and subtypes, avoiding long-term immunosuppressants.
Area of Science:
- Dermatology and immunology, focusing on cutaneous conditions.
Background:
- Urticaria significantly impacts patient quality of life, necessitating effective therapeutic strategies.
- Consensus reached during the International Clinically Oriented ESDR Symposium Urticaria 2000 highlights treatment needs.
Framework:
- The primary treatment recommendation involves nonsedating H1 antihistamines.
- Evidence supports their efficacy in double-blind, placebo-controlled studies.
Implementation:
- Higher than standard doses of H1 antihistamines may be required for optimal patient outcomes.
- Individual variations in urticaria subtypes and treatment response necessitate consideration of alternative therapies.
Implications:
- Long-term use of immunosuppressive agents such as cyclosporine A and corticosteroids is discouraged due to potential adverse effects.
- Personalized treatment approaches are crucial for managing chronic urticaria effectively.
Related Concept Videos
02:06Allergic Reactions
Overview
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...